 CHERRY HILL, N.J., Aug. 11, 2021 GLOBE NEWSWIRE -- Vyant Bio, Inc. Vyant Bio, Company Nasdaq: VYNT, an emerging global drug discovery company, is rapidly identifying small and large molecule therapeutics to treat central nervous system CNS and oncology-related diseases. With leading-edge capabilities in data science, biological and chemical sciences, engineering, and regulatory affairs, Vyant Bio capitalizes on in silico, human cell-derived in vitro disease models, and in vivo discovery technologies to identify novel biological targets and valuable therapeutics for patients. Today, Vyant Bio announced that an investor conference call and webcast will be hosted on Monday, August 16, 2021. 